Douglas Gorman
CBO Puts $1.2T Price Tag on Golden Dome
The estimate is an order of magnitude larger than the $185B figure proposed by Golden Dome chief Gen. Michael Guetlein in March
SOCOM Taps SkyFi to Build Tactical EO Imagery Tools
SkyFi will develop an early prototype of a new sovereign intelligence platform, aimed at giving troops quicker and easier access to geospatial imagery.
Lunar Outpost Closes $30M Series B, Unveils New Rover
The fundraise highlights the huge demand from investors looking to capitalize on NASA’s new vision for the US presence on the Moon.
South Korea Pushes to Commercialize Quantum Research
The quantum age is upon us, and South Korea is angling for a seat at the table.
Scout Space Closes $18M Series A
Plans for expansion include building a new satellite sensor factory outside DC, and nearly doubling Scout’s headcount in the next 18 months.
LiveEO Raises €28M+ to Fund its First Constellation
The German company will use the funds to scale its business, launch its own satellite constellation, and build the tech to meet the growing demand for EO data.
ESA Taps Edge Aerospace for Space Cloud Contract
Under the agreement, announced today, the Luxembourg-based company will develop an architecture and use-case road-map for orbital data centers.
Payload Field Guide: Lunar Rovers
As NASA and its partners push harder toward a sustained human presence on the Moon, mobility is mission-critical. Moon buggies with lawn chairs might’ve been good enough for the Apollo-era, but long-term surface operations depend on lunar rovers that can pull their weight (quite literally). For decades, lunar rovers were the domain of national space…
Space Nuclear Execs Cheer the FY27 Budget Proposal
More than just money, NASA is throwing its full weight behind what Administrator Isaacman sees as the agency’s “logical evolution.”
European Space Firms Raised €1.4B of Private Capital in 2025
Private European capital markets are increasingly comfortable backing space-industry upstarts.
BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in Orbit
BioOrbit is attempting to leverage microgravity to reformulate drugs so that they can be self administered by patients instead of requiring medical staff to administer them.
